PAR : OSE.PA

OSE Immunotherapeutics S.A. — Earnings Estimates

$3.206 EUR

$0.05 (1.46%)

Volume
102.94K
Average Volume
277.94K
Market Capitalization
$75.41M
P/E Ratio
-1.90
Dividend Yield
0.00%
Price Target
Year High
$7.70
Year Low
$2.87
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$1.28

Annual earnings financials

OSE.PA financial data with annual/quarterly toggle

OSE.PA GAAP EPS - Annual & Quarterly

OSE.PA Sales Revenue - Annual & Quarterly

OSE.PA Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

OSE.PA Estimated and Actual Revenue by Quarter
OSE.PA Estimated and Actual EPS by Quarter
OSE.PA Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-06-30 1 -579.96K -579.96K -579.96K -655.18K -655.18K -655.18K
2026-03-30 1 -805.66K -805.66K -805.66K -910.15K -910.15K -910.15K
2025-12-31 1 -686.49K -686.49K -686.49K -775.52K -775.52K -775.52K
2025-09-30 1 -734.14K -734.14K -734.14K -829.35K -829.35K -829.35K
2025-06-30 1 -700.79K -700.79K -700.79K -791.68K -791.68K -791.68K
2023-12-30 4 -29.17M -29.17M -29.17M -32.95M -32.95M -32.95M
OSE.PA Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-06-30 1 - - - 1.5M 1.5M 1.5M
2026-03-30 1 - - - 1.64M 1.64M 1.64M
2025-12-31 1 - - - 1.77M 1.77M 1.77M
2025-09-30 1 - - - 1.49M 1.49M 1.49M
2025-06-30 1 - - - 1.42M 1.42M 1.42M
2023-12-30 4 - - - 59.29M 59.29M 59.29M
OSE.PA Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-06-30 1 1.09M 1.09M 1.09M 0 0 0 0
2026-03-30 1 1.52M 1.52M 1.52M 0 0 0 0
2025-12-31 1 1.3M 1.3M 1.3M 0 0 0 0
2025-09-30 1 1.39M 1.39M 1.39M 0 0 0 0
2025-06-30 1 1.32M 1.32M 1.32M 0 0 0 0
2023-12-30 4 55.07M 55.07M 55.07M 0 0 0 0